This small handheld ECG monitor is capable of capturing a wide range of arrhythmias such as tachycardia, bradycardia, ventricular premature beats (VPBs), pauses and atrial fibrillation.
Simply connect to a smart device with the GEMS™ Mobile ECG App via Bluetooth to take ECG recordings. Recorded ECGs can be transmitted to a physician, clinic or the SMART monitoring ECG reading service or generate your own ECG record in PDF format to show to your physician.
Available OTC the HeartCheck™ CardiBeat allows a user to record a medical grade 30 second single lead ECG. Coupled with the GEMS™ Mobile ECG App a user can save up to a five minute recording from the device. Specific symptom, activity and diary entry information related to the recording can be entered and sent for a review by a physician, clinic or the SMART monitoring ECG reading service.
Now available for sale in the USA and Canada.
COVID-19 Update: Please be advised delivery from both Canada Post and DHL will be delayed due to a surge in online purchasing. We cannot guarantee any shipment delivery time frame.
For use with an Android or iOS smart device running the GEMS Mobile ECG App available free on the Google Play store or Apple App Store.
Click here for more information about the HeartCheck CardiBeat
HeartCheck™ CardiBeat device
USB Charging cable
Soft case travel pouch
1 Included Physician Review*
10 Free Triage Reviews
(Value $19.90 USD)
Shipping Canada Post Expedited Parcel included.
CardioComm Solutions is ISO 13485:2016 certified under the Medical Device Single Audit Plan (MDSAP) for Canada and the US and its products are cleared for sale in the United States, Canada and the European Union. Utilizing a proprietary technology and ECG (signal) viewer unlike any other competitor has, and by offering flexible open ended work flow solutions, CardioComm Solutions provides the right solution for use with the majority of the world’s cardiac event monitors, including those intended for the home and tele-health market.
CardioComm has leveraged its extensive knowledge and experience in the medical markets to develop consumer-use heart rhythm and ECG recording solutions paired with an ECG reading service called SMART Monitoring to extend a person’s ability to monitor their heart health themselves. In 2019, CardioComm secured FDA and Health Canada Class II medical device clearance on the HeartCheck™ CardiBeat ECG monitor and the GEM™ Mobile Smartphone app, the newest additions to the growing number of HeartCheck™ branded/compatible devices. All HeartCheck devices permit the viewing of a person’s actual ECG waveform while a recording is being taken. The GEMS™ Home and Mobile software allows the ECG recording to be viewed and printed as a PDF. Additionally, both the PC and Smartphone GEMS™ software supports a fee-for-service ECG reading service where consumers pay to have their ECGs reviewed for the presence or absence of arrhythmias. The SMART Monitoring ECG reading service allows HeartCheck™ device owners to have ECG readings provided within 30 minutes, on a 24/7/365 basis.
Of noted importance is that the GEMS Mobile app is the only FDA cleared multi-device compatible ECG management app called available as an ECG monitoring solutions that can be offered directly to consumers.